Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Breast Cancer
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
American Society of Clinical Oncology
100%
Guideline Recommendations
100%
College of American Pathologists
100%
Fluorescence in Situ Hybridization
33%
In Situ Hybridization
16%
Invasive Breast Cancer
16%
Immunohistochemical Staining
16%
Gene Copy number
16%
Hybridization Ratio
16%
Proficiency Testing
16%
Immunohistochemistry
8%
Tumor Cells
8%
Protein Expression
8%
Laboratory Assays
8%
Protein-coding Genes
8%
Invasive Tumors
8%
Expert Panel
8%
Reporting Criteria
8%
Exclusion Criteria
8%
Gene Amplification
8%
Testing Laboratory
8%
Board of Directors
8%
Systematic Literature Review
8%
Predictive Marker
8%
Chromosome 17
8%
Assay Performance
8%
Standard Operating Procedures
8%
Negative Value
8%
Performance Test
8%
Competency Assessment
8%
Accreditation
8%
Laboratory Accreditation
8%
Testing Algorithm
8%
Brightfield
8%
Accredited Laboratory
8%
Membrane Staining
8%
Testing Criteria
8%
3-uniform
8%
Testing Requirements
8%
Accreditation Standards
8%
Specimen Handling
8%
Final Overdetermination
8%
Requirement Set
8%
Assay Variation
8%
Anti-human Epidermal Growth Factor Receptor 2
8%
Nursing and Health Professions
Breast Cancer
100%
Practice Guideline
100%
Gamma Urogastrone
100%
Epidermal Growth Factor Receptor 2
100%
Pathologist
100%
Fluorescence in Situ Hybridization
30%
Immunohistochemistry
23%
Staining
23%
Accreditation
15%
In Situ Hybridization
15%
Neoplasm
7%
Laboratory Test
7%
Systematic Review
7%
Specimen Handling
7%
Medicine and Dentistry
Breast Cancer
100%
Pathologist
100%
Epidermal Growth Factor Receptor 2
100%
Gamma Urogastrone
100%
Clinical Oncology
100%
Fluorescence in Situ Hybridization
30%
Immunohistochemistry
23%
In Situ Hybridization
15%
Tumor Cell
7%
Protein Expression
7%
Systematic Review
7%
Gene Amplification
7%
Laboratory Test
7%
Chromosome 17
7%
Predictive Marker
7%
Immunology and Microbiology